Screener
Prestige Consumer Healthcare PBH North American OTC Healthcare — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:15 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001295947-26-000042
| (In thousands) | Three Months Ended June 30, 2026 / North American OTCHealthcare | Three Months Ended June 30, 2026 / International OTCHealthcare | Consolidated |
|---|---|---|---|
| Total segment revenues* | $226,206 | $39,504 | $265,710 |
| Cost of sales | 110,265 | 19,257 | 129,522 |
| Gross profit | 115,941 | 20,247 | 136,188 |
| Advertising and marketing | 28,930 | 5,738 | 34,668 |
| Contribution margin | $87,011 | $14,509 | $101,520 |
| Other operating expenses | 49,000 | ||
| Operating income | $52,520 | ||
| * Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment. |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Prestige Consumer Healthcare's north american OTC healthcare — cost of sales?
- Prestige Consumer Healthcare (PBH) reported north american OTC healthcare — cost of sales of $110.27M in Q2 2026.
- How has Prestige Consumer Healthcare's north american OTC healthcare — cost of sales changed year-over-year?
- Prestige Consumer Healthcare's north american OTC healthcare — cost of sales increased by 19.6% year-over-year, from $92.18M to $110.27M.
- What is the long-term trend for Prestige Consumer Healthcare's north american OTC healthcare — cost of sales?
- Over 4 years (2022 to 2026), Prestige Consumer Healthcare's north american OTC healthcare — cost of sales has grown at a -0.4% compound annual growth rate (CAGR), from $419.16M to $412.7M.
- What does north american OTC healthcare — cost of sales mean?
- Represents the direct costs attributable to the production and distribution of over-the-counter healthcare products within the North American market. This includes raw materials, manufacturing labor, and logistics expenses required to bring consumer health goods to retail shelves. Monitoring this metric helps assess production efficiency and the impact of input cost inflation on segment profitability.
Ask your AI about Prestige Consumer Healthcare's north american otc healthcare — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude